doi.org/10.2174/1381612824666180712110447 Bock-Marquette, I., et al
Image Credit: VectorMine / Shutterstock In a recent study published in the journal Frontiers in Pharmacology , researchers examined the potential role of glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) in treating substance use disorders (SUDs)
Melanotan 2 6mg total per bottle 75 mcg 80 sprays/bottle 10mL bottle 98.687% purity 98.687% purity (HPLC) Third-party tested Freedom Diagnostics Identity confirmed Certificate of Analysis Tested by Freedom Diagnostics 03/23/2026 Tested by Janoshik 11/10/2025 Key Ingredients A cyclic lactam heptapeptide analogue of alpha-MSH studied for its interaction with melanocortin receptors
Journal of Functional Foods, 49 , 235-240
Specifically, the FDAs decision not to include these GLP-1s on the bulk compounding list would not be expected to affect their use by 503A pharmacies
IMMUNE IV DRIP This IV drip was developed to supply the necessary vitamins, minerals and amino acids for improved immune function, which enhances the bodys ability to protect itself -including fighting infections, healing efficiently, repairing cells, and recovering faster